Answer:
C
Explanation:
During their development, many organisms look similar, suggesting that very different organisms may have a common ancestor. - Think of the human fetal neural / spine development which mirrors other species.
Answer:
Energy decreases as it moves up trophic levels because energy is lost as metabolic heat when the organisms from one trophic level are consumed by organisms from the next level. Trophic level transfer efficiency (TLTE) measures the amount of energy that is transferred between trophic levels.
Explanation:
hope this helps!
Answer:
meiosis
Explanation:
Down syndrome is an abnormality that occurs on chromosomes 21, it occurs because chromosomes 21 cannot be separated in meiosis, the pair of chromosomes 21 do not separate and go together to one of the daughter cells. In this way, the oocyte or the resulting sperm will have 24 chromosomes instead of 23. When in conception that oocyte or sperm joins the germ cell of its partner that contributes the 23 chromosomes, the total sum of chromosomes that will have the first cell of the new conceived being will be 47.
<h2>Issues with animal research in bred</h2>
Explanation:
- Since all animals are reared and brought up in a similar domain, they may contrast from animals reproduced in an alternate settlement Animal activist may think that its unscrupulous to utilize animals in look into Working with animals requires IRB conventions that protect the prosperity of the animals, making it difficult to play out certain examinations on them.
- Scientific researchers keep up that despite the fact that animal research, (as some other models in vitro or on the other hand human), doesn't generally convey ideal outcomes for human pertinence, it's still – in blend with important non-creature techniques - the essential method to do research to comprehend living systems and to give the most ideal affirmation of the impacts of new medicines preceding the primary clinical preliminaries in people.
- Clinical preliminaries are not ready to give results with 100% precision because of the huge inconstancy of the human population. The medicines improvement process including in silico, in vitro, pre-clinical (animals) and clinical (human) stages diminish the hazard for the Human population as a whole.
